US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.47

+0.06200.18%

Volume:17.43K

Turnover:602.34K

Market Cap:95.83M

PE:- -

High:34.93

Open:34.93

Low:34.46

Close:34.41

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.82

T/O Rate:0.63%

Dividend:0.26

Dividend Rate:0.75%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Apichope's gout drug AR882 meets primary endpoint in Phase III trial with projected peak sales of 1.95 billion yuan in Greater China

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Champions Oncology Q1 Revenue Rises on Research Services Business

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live

Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen

Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains

Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong

Hybio Pharmaceutical Advances Obesity Treatment with New Triple Agonist Clinical Trial Filing

Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

Amgen to Present at Morgan Stanley Global Healthcare Conference

Sweden's Biovica Q1 Sales Rise on Pharma Services Growth

Sanofi, Regeneron Could Extend Dupixent Patent

Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030

Regeneron Pharmaceuticals, Inc. : Bmo Raises Target Price to $920 from $800

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/IBBQ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.472,"timestamp":1789156800000,"preClose":34.41,"halted":0,"volume":17428,"delay":0,"changeRate":0.001801801801801939,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Pre-Mkt","change":0.062,"latestTime":"09-14 04:49:24 EDT","open":34.93,"high":34.93,"low":34.46,"amount":602342.09186,"amplitude":0.013659,"askPrice":54.81,"askSize":100,"bidPrice":30.06,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.472,"sharesOutstanding":2520001,"nav":34.42313,"aum":95742920.24,"dividendRate":0.007487,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.46,"preClose":34.472,"latestTime":"19:30 EDT","volume":73,"amount":2503.222,"timestamp":1789169407321,"change":-0.012,"changeRate":-0.000348,"amplitude":0},"volumeRatio":0.8243229216538044,"impliedVol":0.1122,"impliedVolPercentile":0.476},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8243229216538044,"shares":2780001,"dividePrice":0.2581,"high":34.93,"amplitude":0.013659,"preClose":34.41,"low":34.46,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.472,"eps":0,"divideRate":0.007487,"volume":17428,"delay":0,"ttmEps":0,"open":34.93,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.26,"twentyDayClose":33.9144,"sixtyDayClose":29.6382},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1130333927","title":"Apichope's gout drug AR882 meets primary endpoint in Phase III trial with projected peak sales of 1.95 billion yuan in Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=1130333927","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130333927?lang=en_us&edition=fundamental","pubTime":"2026-09-11 15:40","pubTimestamp":1789112442,"startTime":"0","endTime":"0","summary":"Apichope Pharmaceutical Group Co.,Ltd. has voluntarily disclosed that its gout innovation drug AR882 has achieved the primary endpoint in a Phase III clinical study for treating gout patients with...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IBBQ","MEDX","BK1574","300723","LNGR","159992","BK0239","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546340","title":"Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546340","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546340?lang=en_us&edition=fundamental","pubTime":"2026-09-11 13:57","pubTimestamp":1789106251,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) just unveiled an update. Vertex Minerals has amended its previously released updated mineral resource estimate f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-confirms-reward-gold-mine-resource-after-asxdriven-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-confirms-reward-gold-mine-resource-after-asxdriven-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0889565916.HKD","LU0417517546.SGD","LU1035775433.USD","LU2456880835.USD","LU2468319806.SGD","LU2362541513.USD","LU1093756325.SGD","LU2462157665.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","BIB","BK4532","BK4567","SGXZ57979304.SGD","LU1778281490.HKD","IE00B19Z9P08.USD","LU1559883803.SGD","BK4588","LU2362541273.HKD","GNMX","VRTX","IBBQ","LU0256863811.USD","LU0058720904.USD","BBH","IBB","IE00B19Z3B42.SGD","LU0109394709.USD","IDNA","IE00B19Z9Z06.USD","IE0002141913.USD","LU1815336091.USD","LU2362540622.SGD","SGDJ","LU2237438978.USD","LU0320765992.SGD","BK4109","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","MTX","PBE","LU2236285917.USD","VERX","BK4533","SG9999001176.SGD","LU2417539215.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115866351","title":"HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=1115866351","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115866351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:13","pubTimestamp":1789096425,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks are experiencing sustained downward pressure in Hong Kong trading. As of the latest update, LEPU BIO (02157) has declined 3.91% to HK$38.05, while REMEGEN (09995) fell...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","LU1226288253.USD","01801","LU0502904849.HKD","LU1993786604.SGD","LU1152091754.HKD","LU0140636845.USD","LU2097828557.USD","LU1152091168.USD","LU2097828805.USD","LU1951186391.HKD","02157","IE00B543WZ88.USD","LU0244354667.USD","LU1226287792.SGD","WRTH","BK1515","IE00BZ08YR35.GBP","IBBQ","LU1226288170.HKD","LU2097828631.EUR","LU2328871848.SGD","BK4585","LU0880133367.SGD","LU1188198961.HKD","LU2097828474.EUR","LU1807302812.USD","LU1969619763.USD","LU2242644610.SGD","LU0067412154.USD","BK1191","LU0463099449.HKD","06978","IE00B5MMRT66.SGD","LU0314109678.HKD","159992","LU2488822045.USD","BK1161","LU1328277881.USD","LU1960683339.HKD","LU0149534421.HKD","09995","LU0607220059.USD","IE0008368742.USD","LU1226287875.USD","PEVC","LU0501845795.SGD","01093","IE00B031HY20.USD","BK1583","LU0455707207.USD","MEDX","LU2039709279.SGD","SG9999004220.SGD","BK1521","LU0315179316.USD","KCAI","BK1589","MCRO","HK0000165453.HKD","KURE","LU1008478684.HKD","LU2097828714.EUR","LU1226287529.USD","LU0326950275.SGD","LU1813983027.USD","LNGR","VXUS","IE00BZ08YT58.USD","LU0072913022.USD","IE00BZ08YS42.EUR","IE0008369823.USD","LU1831875114.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140079980","title":"Regulatory Intervention Halts Trading of Eye-Care Drug Developer Following Suspected IPO Irregularities","url":"https://stock-news.laohu8.com/highlight/detail?id=1140079980","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140079980?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:00","pubTimestamp":1789092059,"startTime":"0","endTime":"0","summary":"Hong Kong's securities regulator has ordered the suspension of trading in shares of Cloudbreak Pharma (02592.HK), citing serious concerns that the company's initial public offering may have been...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","MEDX","LNGR","BK4127","06978","BK1574","KCE","159992","FRHC","REDS","IBBQ","02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515515","title":"Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515515","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:16","pubTimestamp":1789071415,"startTime":"0","endTime":"0","summary":"Vertex Pharma EVP Jasper van Grunsven files initial beneficial ownership statementVertex Pharmaceuticals EVP Jasper van Grunsven filed an initial Form 3 insider ownership statement dated Sept. 8, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL2ylbPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","LU1585245621.USD","TBXU","GNMX","PBE","LU0823416689.USD","SGXZ57979304.SGD","LU1674673428.USD","IBB","IE00B2B36J28.USD","LU0289739699.SGD","VRTX","LU2237438978.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","IE0002270589.USD","LU2236285917.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU0079474960.USD","LU0432979614.USD","LU1035775433.USD","LU0058720904.USD","BK4585","LU1430594728.SGD","LU2089984988.USD","LU2456880835.USD","SG9999001176.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","IE00BJJMRZ35.SGD","BK4532","BBH","BK4533","IE0009355771.USD","LU1093756168.USD","BIB","LU0061475181.USD","IE00B894F039.SGD","IBBQ","LU2417539215.USD","LU0256863811.USD","LU1674673691.USD","IDNA","LU2362540622.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513067","title":"Champions Oncology Q1 Revenue Rises on Research Services Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513067","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513067?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071012,"startTime":"0","endTime":"0","summary":"Champions Oncology Q1 revenue rises on research services businessOverviewUS translational oncology research firm's fiscal Q1 revenue grew 8.8% yr/yrOncology services margin improved to 51% from 43% in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL1N45210N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXH","LU1153584641.USD","PJP","BIB","TBXU","LU0949170426.SGD","LU1074936037.SGD","LU1267930573.SGD","IHE","LU1261432733.SGD","LU1814569148.SGD","LU0211328371.USD","IBB","LU1119994496.HKD","IBBQ","LU1273509221.SGD","LU1883839398.USD","PBE","BMY","LU2293690082.USD","LU0171276677.USD","AMGN","BBH","LU1585245621.USD","LU0211327993.USD","LU0823416689.USD","LU0868494617.USD","LU2357627491.SGD","LU1078025761.USD","LU0827474353.SGD","LU1093756168.USD","LU1323610961.USD","LU2539964713.USD","LU1868836757.USD","LU0203345920.USD","LU0096364046.USD","CSBR","LU0267386448.USD","LU0321505439.SGD","LU0784384876.USD","LU1355424745.HKD","LU1430594728.SGD","LU2360032135.SGD","LU1084165304.USD","LU0211326839.USD","LU1196032939.SGD","AZN.UK","03165","LU0640478417.SGD","LU3187612489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666330597","title":"Amgen’s New Repatha Plaque Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2666330597","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666330597?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:31","pubTimestamp":1789057881,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) is launching a Phase 4 trial called “A Trial Assessing the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-new-repatha-plaque-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-new-repatha-plaque-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1061106388.HKD","LU0320765992.SGD","IE0009355771.USD","IBB","LU2242652126.USD","LU0109394709.USD","IE00BJT1NW94.SGD","ISBC","LU0058720904.USD","AMGN","LU2112291526.USD","BK4139","BK4534","LU1057294990.SGD","BK4566","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU0868494617.USD","LU1571399168.USD","LU2089984988.USD","PJP","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","BIB","BK4585","LU0289739699.SGD","SG9999001440.SGD","BK4581","TBXU","BK4599","LU0122379950.USD","LU1023059063.AUD","BK4211","BK4588","IBBQ","LU2242646821.SGD","BK4533","PBE","LU1983299246.USD","BBH","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666759267","title":"Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666759267","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666759267?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:57","pubTimestamp":1789055857,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals'  patent on Eylea HD is more likely to be retained, with the Patent Trial and Appeal Board, or PTAB, due to issue a final decision on an ongoing patent dispute by March 2027, RBC Capital Markets said in a Thursday note.The patent, which covers Eylea HD's formulation and method of treatment, was issued in 2024 and is set to expire May 10, 2039, according to the note. Alvotech  has challenged the patent, with the PTAB to hear arguments on Dec. 4 and issue a decision by March 3, 2027, the brokerage said.\"Our read and feedback suggests Regeneron is likely in a stronger position, particularly against Alvotech's prior art arguments,\" RBC said. The patent serves as the company's strongest defense for Eylea HD, blocking potential biosimilars, the investment firm noted.RBC has a sector perform rating on Regeneron Pharmaceuticals, with a $737 price target.Price: 795.00, Change: -12.65, Percent Change: -1.57","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0882574055.USD","LU2089984988.USD","LU2106854487.HKD","IBBQ","LU0109394709.USD","TBXU","BK4139","LU0289739699.SGD","BK4585","LU2237438978.USD","LU0823434740.USD","ALVO","LU2362540622.SGD","LU2362541273.HKD","LU0889565916.HKD","LU1974910355.USD","LU2362541513.USD","LU0823434583.USD","LU2468319806.SGD","LU0058720904.USD","LU1917777945.USD","IBB","BBH","REGN","LU0823416689.USD","LU0114720955.EUR","LU2023250504.SGD","LU0053666078.USD","BK4588","USRD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666627592","title":"Dow's 300-Point Drop Led by Losses in Shares of Nvidia Corp., Amgen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666627592","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666627592?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:56","pubTimestamp":1789055760,"startTime":"0","endTime":"0","summary":"DJ Dow's 300-Point Drop Led By Losses In Shares Of NVIDIA Corp., AmgenThis article was automatically generated by MarketWatch using technology from Automated Insights.Behind declines for shares of NVIDIA Corp. and Amgen, the Dow Jones Industrial Average is down Thursday morning.Shares of NVIDIA Corp.  and Amgen  are contributing to the blue-chip gauge's intraday decline, as the Dow  was most recently trading 308 points lower .NVIDIA Corp.'s shares have declined $4.69, or 2.1%, while those of Amgen have fallen $7.83, or 2.0%, combining for a roughly 74-point drag on the Dow.Merck , Sherwin-Williams Co. , and Caterpillar  are also contributing significantly to the decline.A $1 move in any of the benchmark's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0069063385.USD","AIPI","NVDG","SG9999014906.USD","FDN","LU0820562030.AUD","IE0009356076.USD","LU1821325948.USD","BIB","LU1814569148.SGD","LU0029864427.USD","SG9999014914.USD","SGXZ23171101.USD","SG9999017495.SGD","09788","LU2125909593.SGD","IE00BJTD4V19.USD","HK0000306701.USD","LU0109392836.USD","LU0553294199.USD","LU1116320737.USD","LU2125909247.SGD","LU1992135399.USD","LU0143551892.USD","IE00BYXW3230.USD","LU2092937148.SGD","LU2506951792.HKD","HK0000304805.HKD","LU0138981039.USD","LU2028103732.USD","SG9999002224.SGD","LU0323591593.USD","LU1988902786.USD","AIFD","IE00BJLML261.HKD","LU0187121727.USD","LU1934455863.HKD","LU0949170772.SGD","LU0795875086.SGD","LU1323610961.USD","LU0889565833.HKD","LU2065169927.USD","LU1923623000.USD","LU0965509010.AUD","LU1084165304.USD","LU0912757837.SGD","BK4532","HK0000306685.HKD","ANV","NVDQ","LU2087625088.SGD","LU0289739343.SGD","YMAX","IE0009G5SDU7.USD","LFGY","LU0965509283.SGD","LU2097344357.USD","BK4550","SG9999014575.USD","IE00BN29S564.USD","LU1935042991.SGD","LU0174119429.USD","LU0820561909.HKD","LU2242650005.HKD","BBH","IE00B2B36J28.USD","LU2360106780.USD","LU2487616109.SGD","LU1244550221.USD","LU1852331112.SGD","LU1914381329.SGD","LU2413666699.HKD","LU1280957306.USD","SOXY","GRNY","LU0096362180.USD","IE00BHPRN162.USD","LU1267930730.SGD","LU0472753341.HKD","SG9999018865.SGD","LU0289960550.SGD","LU0107464264.USD","IE00B775SV38.USD","SOXQ","LU1069344957.HKD","IE00B4JS1V06.HKD","IE0002141913.USD","NVDA","LU1069347547.HKD","LU0289961442.SGD","LU0390134368.USD","DJIA","LU0353189763.USD","LU2271345857.HKD","DDM","LU0823434583.USD","LU0787776722.HKD","BK4608","LU1066051498.USD","LU2458330243.SGD","MYMmain","LU0823414551.USD","BK4551","LU2462157665.USD","LU1815336760.USD","LU2417539215.USD","LU0238689110.USD","07388","LU2430703095.HKD","LU0689626769.HKD","IE00B775H168.HKD","LU1642822529.SGD","SG9999015952.SGD","LU1868836591.USD","TRFK","SG9999014880.SGD","SGXZ31699556.SGD","BK4533","LU2211815571.USD","NVDD","LU0823421416.USD","LU0868494617.USD","HK0000320264.USD","LU2242646821.SGD","LU2896262040.SGD","IE0003U64NQ7.SGD","IE00BWXC8680.SGD","LU1633808545.USD","LU0096364046.USD","IE0004086264.USD","BK4614","NVD3.UK","UDOW","LU2462591350.SGD","SG9999015978.USD","LU1267930573.SGD","LU1992135472.HKD","LU0175139822.USD","IETC","BK4605","LU1934455194.USD","LU2089284900.SGD","2NVD.UK","BK4554","LU2237443622.USD","IE00B3S45H60.SGD","LU2023250330.USD","LU2272731865.HKD","LU0158827948.USD","LU2860962120.EUR","LU1732800096.USD","NVC","LU0820561818.USD","NVDX","LU2552382058.USD","LU0345768740.USD","LU0048584097.USD","LU1064131342.USD","LU1116320901.HKD","LU2097344431.USD","SG9999014567.USD","IE000W1ABFV2.USD","LU2430703178.SGD","LU0058720904.USD","LU0266013472.USD","AGOX","DOG","NVIW.SI","LU0417517546.SGD","LU0348723411.USD","LU1732799900.SGD","VGT","IE00BJJMRZ35.SGD","LU0345768153.USD","ARTY","LU0965509101.SGD","LU2023251221.USD","LU0347712357.USD","LU2999663052.SGD","LU0882574139.USD","LU2249611893.SGD","LU0823414478.USD","LU1839511570.USD","SG9999015341.SGD","LU1989772840.SGD","LU1127390331.HKD","LU1815333072.USD","LU0082616367.USD","LU1645745479.HKD","LU2272731782.SGD","LU2236285917.USD","LU1861215975.USD","LU1035773651.USD","LU2089985449.USD","LU2111349929.HKD","DIPS","FAI","IE00BKPKM429.USD","LU0868494708.USD","VUG","CLSE","LU0198837287.USD","LU0689472784.USD","LU0786609619.USD","LU2463028550.USD","LU2552382132.HKD","LU0738911758.USD","THMR","SDOW","LU0211328371.USD","LU2750360641.GBP","SNPE","LU0395794307.EUR","IE00BMPRXR70.SGD","SNVD.UK","LU2458330169.SGD","LU0122379950.USD","LU0345769631.USD","GAMR","LU1861220033.SGD","LU1951198990.SGD","LU2237957902.USD","LU0345770308.USD","LU0158827781.USD","LU1316542783.SGD","LU2326559502.SGD","LU2047632596.USD","LU2294711713.HKD","IE00B4R5TH58.HKD","LU2054465674.USD","NVDB","SMH","LU2491049909.HKD","LU2168564222.USD","LU2357125470.USD","NVDY","LU2242652126.USD","SG9999015986.USD","SGXZ51526630.SGD","IE000KEQY171.SGD","VT","LU0957791311.USD","LU0053666078.USD","IE00B5TLWC47.USD","LU2456880835.USD","LU2100268510.USD","SGXZ81514606.USD","LU0861579265.USD","LU1935043536.SGD","LU2505996681.GBP","IE00BFTCPJ56.SGD","LU0823434740.USD","LU0072462426.USD","LU0081259029.USD","LU0889565916.HKD","BK4585","SHOC","LU2125909759.SGD","LU1035775433.USD","LU0070217475.USD","BK4543","NVDL","VYM","LU2237443978.SGD","IE00B19Z8X17.USD","LU1880398554.USD","LU1923622614.USD","09388","LU1989764664.SGD","LU2237443382.USD","LU1496350502.SGD","IE0009355771.USD","LU1861127337.USD","LU1917777945.USD","LU1791710582.SGD","BK4527","LU1400636574.HKD","LU1804176565.USD","LU2265009873.SGD","LU2168563687.JPY","NVII","IE00BJJMRY28.SGD","BK4141","LU1868836757.USD","LU2473716301.USD","IE00BDCRKT87.USD","LU2148611432.USD","LU2931357623.SGD","IE0034235188.USD","IE0034235303.USD","TBXU","SG9999004303.SGD","IE0005OL40V9.USD","JGRO","BK4566","LU0672654240.SGD","LU2413666426.HKD","LU2357305700.SGD","USD","LU0203201768.USD","LU0080751232.USD","LU1691799644.USD","SG9999015945.SGD","LU0265550946.USD","IE00BQXX3F31.USD","IE0004445015.USD","LU2954938101.SGD","LU1868837136.USD","LU0661504455.SGD","LU0545039389.USD","LU1366192091.USD","LU1935043023.USD","AMGN","LU2023250504.SGD","LU2106854487.HKD","LU2264538146.SGD","LU2433249047.HKD","SG9999018857.SGD","LU2125154935.USD","LU1144417596.USD","WISE","BK4599","CMAG","LU1145028129.USD","LU2452424414.USD","LU0965508806.USD","LU2361045086.USD","FDVV","LU1267930490.SGD","LU0308772762.SGD","LU2108987350.USD","NVD2.UK","LU0133085943.USD","HK0000914660.USD","XLI","LU0642271901.SGD","LU2381873111.SGD","LU2461242641.AUD","LU0127658192.USD","LU2065170008.USD","LU0726765562.USD","SCHD","ESUM","SG9999002232.USD","IE0004445239.USD","07788","IE00B5949003.HKD","CHPX","LU0061474705.USD","LU1061106388.HKD","LU0225283273.USD","LU1880398471.USD","NVDU","VYMI","IE00B19Z8W00.USD","LU0640476718.USD","BK4592","LU0444971666.USD","IE000YTNTUN2.SGD","LU2077746001.SGD","LU0203202063.USD","LU0323240290.USD","LU0210536198.USD","LU1674673428.USD","LU0320765992.SGD","LU0528227936.USD","IE00BFSS7M15.SGD","LU2133065610.SGD","TOPT","USXF","LU2279689827.SGD","LU2168564149.EUR","IBB","LU1400636491.USD","LU1244550494.USD","NVDS.UK","LU1429558221.USD","LU2750360997.AUD","TTEQ","LU0985320562.USD","LU0077335932.USD","LU1935043452.HKD","LU2468319806.SGD","IBBQ","IE00B4YYXB79.USD","LU0323239441.USD","LU0708995401.HKD","LU2471134796.USD","3NVD.UK","IE00BKDWB100.SGD","BK4529","LU2491050154.USD","LU1400636657.SGD","LU0316494557.USD","LU0788109477.HKD","PJP","LU0256863902.USD","IE00BK4W5M84.HKD","SNVDAmain","NVYY","ABFL","LU2756315318.SGD","LU2756315664.SGD","LU0345769128.USD","LU2237438978.USD","LU2403377893.USD","LU0354030438.USD","LU1718418525.SGD","LU1791710400.SGD","IE00BD6J9T35.USD","LU2491050071.SGD","LU0511384066.AUD","LU1989764748.USD","BK4503","LU1623119135.USD","NVD","LU2083900584.USD","LU1037948897.HKD","LU2420271590.USD","LU2592432038.USD","IE00BJJMRX11.SGD","HK0000532082.HKD","LU0109391861.USD","LU0310799852.SGD","LU2237443549.SGD","LU0823421333.USD","LU0267386448.USD","LU2361044865.SGD","IE000ITXATA3.USD","LU0094547139.USD","LU1435385759.SGD","IE00B3M56506.USD","LU2168564495.EUR","LU0256863811.USD","SG9999001424.SGD","LU1699723380.USD","LU2322448957.HKD","TYLG","LU0345770993.USD","LU2637965513.SGD","ROM","LU2247934214.USD","LU1066051225.USD","BK4139","LU2347655156.SGD","LU2347655073.USD","LU2213496289.HKD","LU2361044949.HKD","DJX","LU1366333091.USD","IE00BKVL7J92.USD","LU1989772923.USD","LU2125909916.SGD","LU0354030511.USD","LU2746668461.USD","LU0157215616.USD","LU2065171402.SGD","LU0964807845.USD","LU2360032135.SGD","LU2191332357.HKD","LU0215105999.USD","LU2322448791.USD","DVY","LU0210533765.USD","SG9999015358.SGD","LU0006306889.USD","LU2505996509.AUD","LU1674673691.USD","SOXX","BK4534","SG9999000418.SGD","LU1951200564.SGD","LU0898699433.AUD","LU0234572021.USD","BK4549","IE00BDRTCR15.USD","LU1119994496.HKD","LU1983260115.SGD","IE0001KFT4U8.USD","LU1023059063.AUD","LU1153585028.USD","IE00B3SWFQ91.USD","LU0170899867.USD","LU0942090050.USD","LU0557290698.USD","LU1935042215.USD","LU1496350171.SGD","IE00BZ199S13.USD","LU0234570918.USD","LU0957808578.USD","FDTX","IE00BQXX3D17.EUR","LU1868837300.USD","SCHG","LU1868836914.USD","LU0097036916.USD","LU0106261372.USD","LU0353189680.USD","LU0124676726.USD","BK4548","LU2746668974.SGD","LU0494093205.USD","LU0979878070.USD","LU1551013342.USD","LU0210528500.USD","SPTE","LU1979441026.SGD","LU0466842654.USD","LU1261432733.SGD","LU2168564065.EUR","LU1721428933.USD","LU1935042488.USD","IE00BJT1NW94.SGD","LU0211327993.USD","LU2250418816.HKD","LU0444973449.USD","IE00BJTD4N35.SGD","LU0708994859.HKD","ILDR","SG9999001440.SGD","BK4587","LU2286300806.USD","LU2087621335.USD","SG9999014542.SGD","LU0079474960.USD","LU1629891620.HKD","SG9999014898.SGD","HK0000819398.USD","LU2471134523.USD","LU2471134952.CNY","LU0274383776.USD","LU0342679015.USD","IE00B1BXHZ80.USD","LU0011850046.USD","LU1003077747.HKD","LU2360107168.USD","EFIV","LU2543165471.USD","LU2242649171.HKD","LU0276348264.USD","LU0719512351.SGD","LU1066051811.HKD","SG9999014559.SGD","LU1923622291.USD","LU2063271972.USD","LU0154236417.USD","LU1670756490.USD","IE00BK4W5L77.USD","LU2462591277.SGD","IE0004091025.USD","LU2092627202.USD","LU1244550577.SGD","LU0057025933.USD","LU2244417387.USD","LU0320765059.SGD","IE0034235295.USD","LU1803068979.SGD","LU2471134879.HKD","LU1551013425.SGD","SDY","LU1242518931.SGD","SGXZ99366536.SGD","IE000Q6AESB8.SGD","LU2237443895.HKD","MGK","LU2237443465.HKD","LU2430703251.USD","NVDO","NVDW","LU2602419157.SGD","LU0061475181.USD","SGXZ80539844.SGD","LU2394011477.USD","NVDS","LU0476273544.USD","LU0795875169.SGD","TEK","IE00BFSS8Q28.SGD","NULC","LU1066053197.SGD","DGRO","LU1778281490.HKD","LU0310800379.SGD","PBE","LU0251132253.USD","TTXU","LU1983299246.USD","LU1202635105.USD","LU1720051017.SGD","LU1934455277.USD","IE00B7KXQ091.USD","FTEC","LU2272731600.USD","LU2065171311.SGD","LU0265550359.USD","HK0000304797.USD","LU2290526834.HKD","CNEQ","BK4581",".DJI","ESLG","LU2089984988.USD","METV","LU1057294990.SGD","LU2552382215.SGD","LU0109394709.USD","SMHX","BK4567","LU1548497426.USD","LU0683600562.USD","IE00B19Z9505.USD","BK4588","IE00BMPRXN33.USD","BK4612","LU0943347566.SGD","LU1037948541.HKD","04332","IE00BQXX3C00.GBP","HK0000320223.HKD","LU1571399168.USD","LU1974910355.USD","LU0056508442.USD","LU0061474960.USD","LU0289739699.SGD","IXN","DGRW","BK4579","LU3102509885.SGD","IE00B1XK9C88.USD","GB00BDT5M118.USD","LU0724617625.USD","LU1712237335.SGD","IE00BMPRXQ63.HKD","LU1242518857.USD","LU2237957811.SGD","CHAT","DXD","LU2112291526.USD","LU1232071149.USD","LU2125154778.USD","LU0128525929.USD","HK0000914686.HKD","DIA","XLK","LU1720051108.HKD","IE00BZ1G4Q59.USD","BK4598","LU2089283258.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173269814","title":"Market Wrap September 10: Innovation Drug Shares Dip Amid Clinical Setback, Bank Stocks Post Modest Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1173269814","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173269814?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:55","pubTimestamp":1789030552,"startTime":"0","endTime":"0","summary":"Hong Kong equities extended their losing streak as escalating Middle East tensions and rising oil prices stoked inflation concerns. A combination of factors, including clinical trial risk events,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IBBQ","TALV","BKDV","BK4585","PY","06978","PRF","ROPE","EQRR","VLUE","159992","VMAX","SWP","MEDX","BK1574","LNGR","VALQ","FDN","DFLV","BK4550","VTV","SPVM","VUSV","BK4588","CGVV","ABEQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666661625","title":"Sino Biopharmaceutical Stock Slides 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666661625","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666661625?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:32","pubTimestamp":1789029120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 2.3% to 5.48 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.3% to 24954.47.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 38% short of its 52-week high of HK$8.86, which the company reached Sept. 15.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.6% and Amgen Inc. remained unchanged.Trading volume totaled 79.1 million shares, compared to the 50-day average of 100.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BIB","LU0868494617.USD","LU1571399168.USD","BBH","BK1515","BK4585","IE00BZ08YR35.GBP","IE00B4R5TH58.HKD","LU0109394709.USD","LU0058720904.USD","IE0009355771.USD","IE00BZ08YS42.EUR","BK4534","BK4533","LU2242652126.USD","BK1589","PJP","BK4139","BK1191","BK4581","LU1983299246.USD","BK4599","IE00BFTCPJ56.SGD","SG9999001440.SGD","HK0000165453.HKD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2112291526.USD","TBXU","AMGN","IE0002141913.USD","LU1061106388.HKD","LU1023059063.AUD","IE00BZ08YT58.USD","BK1521","PBE","IBB","LU0889565916.HKD","IBBQ","BK4566","BK4588","IE00B2B36J28.USD","LU0122379950.USD","LU2468319806.SGD","01177","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198884233","title":"Hybio Pharmaceutical Advances Obesity Treatment with New Triple Agonist Clinical Trial Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=1198884233","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198884233?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:28","pubTimestamp":1789028880,"startTime":"0","endTime":"0","summary":"Hybio Pharmaceutical Co.,Ltd. (300199.SZ) has announced the receipt of an official acceptance notice from China's National Medical Products Administration for its clinical trial application of the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","BK0028","BMED","IBBQ","BK0239","IBBJ","BK0188","BK0070","300199","PSYK","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192676541","title":"Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=1192676541","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192676541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:08","pubTimestamp":1789006103,"startTime":"0","endTime":"0","summary":"Investment banking firm Northeast Securities Co.,Ltd. has released a research report indicating that the high prosperity of the overseas innovative drug industry is set to continue, allowing domestic...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK0183","BK1574","WX","06978","BK0028","BK0188","BK0276","000686","159992","BK1161","LNGR","MEDX","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103728541","title":"AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1103728541","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103728541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:26","pubTimestamp":1789000007,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its lead artificial intelligence-powered investigational drug, Rentosertib (also known as ISM001-055/INS018_055), has achieved a significant clinical milestone...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","IBBQ","NEWZ","AIBU","AIQU","QID","SQQQ","02834","06978","NOCT","CPNQ","07266","CWC","QQA","QQQM","GK","TQQY","09834","09086","QTOC","PBOT","PSQ","QQQX","QMAR","FWD","BK1574","CHAT","QQQ","WPAI","AGIX","DQJN","03455","MDTX","MEDX","OGIG","07261","07568","AQGX","LCLG","QDEC","AIFD","QLD","TECY","KOMP","NBDS","NJAN","03086","IBBJ","MFIG","NAPR","03696","BMED","PSYK","LNGR","TARK","TQQQ","NJUL","07522","ARTY","QSWN","VUSE","159992","161631","MVPS","03034","BK4593","GPIQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537110","title":"Amgen to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537110","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537110?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984088,"startTime":"0","endTime":"0","summary":"Amgen to present at Morgan Stanley Global Healthcare ConferenceAmgen will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 15, 2026 at 11:30 a.m. ET.Jay Bradner, head of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9C0c81:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1548497426.USD","LU0006306889.USD","PJP","LU0971096721.USD","BK4599","LU1064131342.USD","KBWB","TBXU","IE0002141913.USD","BBH","LU1720051108.HKD","LU0889565916.HKD","IBB","LU0528227936.USD","PBE","LU1732799900.SGD","SG9999001440.SGD","LU1983299246.USD","IE0009355771.USD","LU0234570918.USD","LU0314104364.USD","LU2487616109.SGD","LU1244550221.USD","LU1989772923.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU0390134368.USD","LU0267386448.USD","IE00B4R5TH58.HKD","LU0882574139.USD","BK4534","LU2112291526.USD","LU0109394709.USD","LU1791710400.SGD","BK4516","LU2264538146.SGD","IBBQ","LU2089984988.USD","BK4588","LU1732800096.USD","AMGN","LU0106831901.USD","LU1989772840.SGD","BIB","BK4566","BK4533","IAI","LU0058720904.USD","LU0912757837.SGD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311205","title":"Sweden's Biovica Q1 Sales Rise on Pharma Services Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311205","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311205?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:58","pubTimestamp":1788969519,"startTime":"0","endTime":"0","summary":"Sweden's Biovica Q1 sales rise on Pharma Services growthOverviewSweden cancer biomarker assay developer's fiscal Q1 sales grew 56% yr/yr, driven by Pharma ServicesOperating loss widened, reflecting SE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N4510RS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM643.USD","AMGN","03165","EVMN","IBB","PBE","LU0171293334.USD","LU0963555726.SGD","LU1934455863.HKD","MCK","PJP","LU1196032939.SGD","LU1989771016.USD","LU0784385170.HKD","LU0792757196.USD","PHVS","LU1481600234.SGD","LU2089284900.SGD","LU0310800379.SGD","TBXU","LU0920840948.USD","LU1084165304.USD","AZN.UK","LU0526926950.USD","IE0002141913.USD","LU1291159041.SGD","LU0077335932.USD","LU1057294990.SGD","LU1506573853.SGD","BK4534","LU2293690082.USD","LU0128525689.USD","LU1496350502.SGD","BIB","LU2089984988.USD","LU2279689827.SGD","LU1814569148.SGD","LU0857590862.USD","IBBQ","LU0920783379.SGD","LU0171276677.USD","LU0887340254.USD","LU2237443978.SGD","LU0345777147.USD","SG9999001176.USD","BBH","LU0266013472.USD","LU1064927863.SGD","LU1487256676.USD","LU0251131958.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666394625","title":"Sanofi, Regeneron Could Extend Dupixent Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2666394625","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666394625?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:49","pubTimestamp":1788965340,"startTime":"0","endTime":"0","summary":"1449 GMT - French drugmaker Sanofi and U.S. partner Regeneron Pharmaceuticals could extend the U.S. patent on their blockbuster anti-inflammatory drug Dupixent by two years to 2033, RBC Capital Markets analysts write in a research note. RBC sees a 70% chance of this happening and says the move could help Sanofi as it reshapes its portfolio. \"Sanofi is navigating a pivotal transition amid near-term challenges,\" the analysts say. Despite Dupixent's strength, investors want proof of diversified growth and acquisitions seem likely, they add. RBC starts coverage of Sanofi with a sector perform recommendation and a target price of 80 euros. Shares fall 0.9% to 74.05 euros.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4007","LU2023250504.SGD","LU0109394709.USD","LU0889565916.HKD","LU2106854487.HKD","LU0823434740.USD","LU2089984988.USD","LU2237438978.USD","LU1917777945.USD","BK4139","LU2362540622.SGD","LU0823416689.USD","BK4585","TBXU","LU0114720955.EUR","LU2468319806.SGD","LU0320765992.SGD","LU1974910355.USD","LU0053666078.USD","LU0882574055.USD","IBBQ","LU0823434583.USD","BK4588","LU0289739699.SGD","LU2362541273.HKD","LU2362541513.USD","REGN","IE00BFXG1179.USD","SNYNF","IBB","SNY","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107437767","title":"Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=1107437767","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107437767?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:11","pubTimestamp":1788959461,"startTime":"0","endTime":"0","summary":"During the 2026 Yabuli Forum Summer Annual Meeting, Henlius (02696.HK) Executive Director and CEO Dr. Zhu Jun outlined the company's \"systematic globalization\" strategy in an in-depth conversation,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","BK1161","IBBQ","02696","HK0000306701.USD","PPH","LU2272731865.HKD","BK4585","LU2473716301.USD","06978","HK0000306685.HKD","IE00B5TLWC47.USD","LU2272731782.SGD","XPH","LU1992135399.USD","159992","MEDX","BK1574","LNGR","IBB","LU1992135472.HKD","LU2322448957.HKD","HK0000165453.HKD","LU2322448791.USD","HK0000320264.USD","BK4588","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666639580","title":"Regeneron Pharmaceuticals, Inc. : Bmo Raises Target Price to $920 from $800","url":"https://stock-news.laohu8.com/highlight/detail?id=2666639580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666639580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:35","pubTimestamp":1788953718,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN451104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","IBBQ","LU0114720955.EUR","LU1974910355.USD","LU2106854487.HKD","LU2362540622.SGD","LU0882574055.USD","BBH","LU2468319806.SGD","BK4139","LU2237438978.USD","REGN","LU0053666078.USD","LU0823434740.USD","LU2089984988.USD","LU0823416689.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","LU2023250504.SGD","LU0109394709.USD","LU2362541273.HKD","TBXU","LU0823434583.USD","LU2362541513.USD","BK4585","LU1917777945.USD","LU0058720904.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587822","title":"Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Waters (WAT) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587822?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:50","pubTimestamp":1788951011,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Assembly Biosciences (ASMB), Waters (WAT) and Amge...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-waters-wat-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-assembly-biosciences-asmb-waters-wat-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2413666699.HKD","IBBQ","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0690374961.EUR","LU2404859667.USD","AMGN","SG9999001440.SGD","TBXU","WAT","LU1721428933.USD","BK4533","BK4581","ASMB","LU0320765992.SGD","LU2404859741.USD","BK4566","LU0868494617.USD","BK4139","LU1023059063.AUD","GB00B4LPDJ14.GBP","GB00B4QBRK32.GBP","IE00B4R5TH58.HKD","XBI","LU0347712357.USD","LU0029874061.USD","BBH","IBB","LU0058720904.USD","IE00B2B36J28.USD","LU2242652126.USD","PJP","HCSG","LU2112291526.USD","LU2242646821.SGD","PBE","LU0109394709.USD","LU2089984988.USD","LU2468319806.SGD","LU0122379950.USD","LU1983299246.USD","LU0728928796.USD","BK4585","XLV","IE0002141913.USD","BK4588","LABU","BIB","LU1061106388.HKD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}